Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Polyphor
Polyphor
Activities:
Research & Development
X
LinkedIn
Trending Articles
ICROM has acquired HOLODIAG
ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services of...
Blood plasma processing: when every drop counts
Plasma derivatives obtained from human blood support the treatment of various diseases — from haemophilia and antigen defects to COVID-19. The products are in high demand and...
Rentschler Biopharma boosts UK end-to-end lentiviral vector manufacturing capabilities
The company can now develop and produce LVVs for the biopharmaceutical market, which have a high potential in treating a range of diseases
IC Biomedical confirms Biopharma Group as its cryogenic storage vessel service provider
IC Biomedical has designated Biopharma Group as its Premier Service Provider for the full range of cryogenic storage vessels across the UK and Ireland
What’s the difference between a factory acceptance test and site acceptance testing?
When manufacturing complex machinery in industries such as pharmaceuticals or fine chemicals, extensive equipment testing must be carried out before commissioning
Upcoming event
Boston Biotech Week
23-26 September, 2024 | Convention and exhibition | Boston, US
See all
Related Content
Research & Development
Polyphor and Wellcome Trust to develop novel antibiotics against multi-drug resistant Gram-negative pathogens
Final milestone reached ahead of schedule triggering payment of a CHF 0.97 million convertible loan amount
Research & Development
Kalina Scott appointed new CFO of Polyphor
Research & Development
New hope against antibiotic resistance: Outer-Membrane Protein Targeting Antibiotics
OMPTA platform could bring further new important therapies in the treatment of Gram-negative pathogens
Recruitment
Debra Barker appointed as new CMDO of Polyphor
Polyphor has announced the appointment of Dr Debra Barker, MD and MSc, to the role of Chief Medical and Development Officer (CMDO)
Research & Development
Polyphor appoints Michael Altorfer as Chief Executive
He replaces Jean-Pierre Obrecht, who will continue as a member of the Board of Directors
Research & Development
Roche signs licensing agreement with Polyphor to combat multi-drug resistant infections
Makes an upfront payment of CHF35m to Polyphor in deal that could be worth up to CHF500m
Research & Development
Polyphor signs MacroFinder collaboration with Boehringer Ingelheim
Will use technology to identify drug candidates addressing therapeutic targets chosen by BI
Subscribe now